Publication:
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress.

dc.contributor.authorMartín-Adrados, Beatriz
dc.contributor.authorWculek, Stefanie K
dc.contributor.authorFernández-Bravo, Sergio
dc.contributor.authorTorres-Ruiz, Raúl
dc.contributor.authorValle-Noguera, Ana
dc.contributor.authorGomez-Sánchez, Maria José
dc.contributor.authorHernández-Walias, José Carlos
dc.contributor.authorFerreira, Frederico Moraes
dc.contributor.authorCorraliza, Ana María
dc.contributor.authorSancho, David
dc.contributor.authorEsteban, Vanesa
dc.contributor.authorRodriguez-Perales, Sandra
dc.contributor.authorCruz-Adalia, Aránzazu
dc.contributor.authorNakaya, Helder I
dc.contributor.authorSalas, Azucena
dc.contributor.authorBernardo, David
dc.contributor.authorCampos-Martín, Yolanda
dc.contributor.authorMartínez-Zamorano, Elena
dc.contributor.authorMuñoz-López, Diego
dc.contributor.authorGómez Del Moral, Manuel
dc.contributor.authorCubero, Francisco Javier
dc.contributor.authorBlumberg, Richard S
dc.contributor.authorMartínez-Naves, Eduardo
dc.contributor.funderMinisterio de Ciencia e Innovación (España)es_ES
dc.contributor.funderComunidad de Madrid (España)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)es_ES
dc.date.accessioned2023-09-05T09:09:38Z
dc.date.available2023-09-05T09:09:38Z
dc.date.issued2023
dc.description.abstractINTRODUCTION The Unfolded Protein Response, a mechanism triggered by the cell in response to Endoplasmic reticulum stress, is linked to inflammatory responses. Our aim was to identify novel Unfolded Protein Response-mechanisms that might be involved in triggering or perpetuating the inflammatory response carried out by the Intestinal Epithelial Cells in the context of Inflammatory Bowel Disease. METHODS We analyzed the transcriptional profile of human Intestinal Epithelial Cell lines treated with an Endoplasmic Reticulum stress inducer (thapsigargin) and/or proinflammatory stimuli. Several genes were further analyzed in colonic biopsies from Ulcerative Colitis patients and healthy controls. Lastly, we generated Caco-2 cells lacking HMGCS2 by CRISPR Cas-9 and analyzed the functional implications of its absence in Intestinal Epithelial Cells. RESULTS Exposure to a TLR ligand after thapsigargin treatment resulted in a powerful synergistic modulation of gene expression, which led us to identify new genes and pathways that could be involved in inflammatory responses linked to the Unfolded Protein Response. Key differentially expressed genes in the array also exhibited transcriptional alterations in colonic biopsies from active Ulcerative Colitis patients, including NKG2D ligands and the enzyme HMGCS2. Moreover, functional studies showed altered metabolic responses and epithelial barrier integrity in HMGCS2 deficient cell lines. CONCLUSION We have identified new genes and pathways that are regulated by the Unfolded Protein Response in the context of Inflammatory Bowel Disease including HMGCS2, a gene involved in the metabolism of Short Chain Fatty Acids that may have an important role in intestinal inflammation linked to Endoplasmic Reticulum stress and the resolution of the epithelial damage.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by grants from Ministerio de Ciencia e Innovación (MCIN) from Spain [SAF2016-78711R and PID202-11794 to EM-N and FJC]; Comunidad de Madrid [B2017/BMD-3727 to EMN and FJC]; Comunidad de Madrid (REACT-UE, ANTICIPA-CM Ref. PR38/21-24) to E.M-N and HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679 to FJC the European Union’s Horizon 2020 research and innovation program [ERC-2016- Consolidator Grant 725091 to DS]; MCIN/AEI/10.13039/ 501100011033 [PID2019-108157RB to DS]; la Caixa Foundation (ID 100010434) [LCF/BQ/PR20/11770008 to SW]; Instituto de Salud Carlos III (ISCIII) [PI18/00348 to VE]; ISCIII [PI21/01641 to RT-R]; Spanish National Research and Development Plan, ISCIII and FEDER [PI17/02303 and PI20/01837 to SR-P]; Proyecto Desarrollo Tecnológico [DTS19/00111 to SR-P], AEI/MICIU EXPLORA Project [BIO2017-91272-EXP to SR-P]; Programa Estratégico Instituto de Biologıa y Gene ́ ́ tica Molecular (IBGM), Junta de Castilla y León (CCVC8485) [PID2019-104218RB-I00 to DB]; NIH [DK088199 to RB] and Universidad Complutense de Madrid (UCM 920631) [CT42/ 18-CT43/18 and EB15/21 to BM-A].es_ES
dc.format.page1185517es_ES
dc.format.volume14es_ES
dc.identifier.citationFront Immunol. 2023 Jun 30;14:1185517.es_ES
dc.identifier.doi10.3389/fimmu.2023.1185517es_ES
dc.identifier.e-issn1664-3224es_ES
dc.identifier.journalFrontiers in immunologyes_ES
dc.identifier.pubmedID37457727es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16409
dc.language.isoenges_ES
dc.publisherFrontiers Mediaes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SAF2016-78711Res_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID202-11794es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/B2017/BMD-3727es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PR38/21-24es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MCIN/AEI/10.13039/501100011033es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-108157RBes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/LCF/BQ/PR20/11770008es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI18/00348es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI21/01641es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI17/02303es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI20/01837es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/DTS19/00111es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/BIO2017-91272-EXPes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-104218RB-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CT42/18-CT43/18es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/EB15/21es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Inmunobiologíaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshColitis, Ulcerativees_ES
dc.subject.meshInflammatory Bowel Diseaseses_ES
dc.subject.meshHumanses_ES
dc.subject.meshCaco-2 Cellses_ES
dc.subject.meshThapsigargines_ES
dc.subject.meshEndoplasmic Reticulum Stresses_ES
dc.subject.meshEpithelial Cellses_ES
dc.subject.meshHydroxymethylglutaryl-CoA Synthasees_ES
dc.titleExpression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationad9522f7-08bb-4f31-b590-f2faf6836ac8
relation.isAuthorOfPublication58aa2591-8084-4500-bfe4-8f2c54e398e9
relation.isAuthorOfPublicationf6b117a4-bcfa-43f3-97cb-1b29910a0155
relation.isAuthorOfPublication.latestForDiscoveryad9522f7-08bb-4f31-b590-f2faf6836ac8

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Expression of HMGCS2 in intestinal_Front Immunol_2023.pdf
Size:
7.24 MB
Format:
Adobe Portable Document Format
Description:
Artículo